Form 4 Tracker
Julie Rubinstein

President and COO · 15 filings · Latest: Apr 27, 2026

Adaptive Biotechnologies Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADPT
RUBINSTEIN JULIEMar 11, 2026
Proposed Sale
$14.52122,523$1.8M
ADPT
Julie RubinsteinPresident and COOMar 13, 2026
Sale
$12.9619,060$247.0K507,934
ADPT
Julie RubinsteinPresident and COOMar 13, 2026
Option Exercise
$6.5514,722$96.4K526,994
ADPT
Julie RubinsteinPresident and COOMar 12, 2026
Sale
$12.8619,060$245.0K512,272
ADPT
Julie RubinsteinPresident and COOMar 12, 2026
Option Exercise
$6.5514,722$96.4K531,332
ADPT
Julie RubinsteinPresident and COOMar 11, 2026
Option Exercise
$6.5514,722$96.4K535,670
ADPT
Julie RubinsteinPresident and COOMar 11, 2026
Sale
$13.29141,583$1.9M516,610
ADPT
Julie RubinsteinPresident and COOMar 10, 2026
Sale
$14.6819,460$285.7K643,471
ADPT
Julie RubinsteinPresident and COOMar 10, 2026
Option Exercise
$6.7015,122$101.3K662,931
ADPT
Julie RubinsteinPresident and COOMar 9, 2026
Sale
$14.7930,941$457.6K647,809
ADPT
Julie RubinsteinPresident and COOMar 9, 2026
Option Exercise
$9.0526,603$240.7K678,750
ADPT
Julie RubinsteinPresident and COOMar 6, 2026
Sale
$15.1430,941$468.4K652,147
ADPT
Julie RubinsteinPresident and COOMar 6, 2026
Option Exercise
$9.0526,603$240.7K683,088
ADPT
Julie RubinsteinPresident and COOMar 5, 2026
Sale
$16.0030,941$495.1K575,235
ADPT
Julie RubinsteinPresident and COOMar 5, 2026
Option Exercise
$9.0526,603$240.7K606,176
ADPT
Julie RubinsteinPresident and COOMar 4, 2026
Sale
$16.6030,941$513.6K579,573
ADPT
Julie RubinsteinPresident and COOMar 4, 2026
Option Exercise
$9.0526,603$240.7K610,514
ADPT
Julie RubinsteinPresident and COOMar 3, 2026
Sale
$15.6730,941$484.8K583,911
ADPT
Julie RubinsteinPresident and COOMar 3, 2026
Option Exercise
$9.0526,603$240.7K614,852
ADPT
JULIE RUBINSTEINMar 3, 2026
Proposed Sale
$16.121,206,661$19.5M

← Previous

Page 4 of 4